| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 23,665 | $763.10 | $18,058,643.25 | - | +40.5% | - | |
| Sep 19, 2025 | AQST Aquestive Therapeutics, Inc. | Barber Daniel72 | President And CEO | Sell | 400 | $6.00 | $2,400.00 | - | +2.5% | - | |
| Sep 18, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $406.17 | $4,467,908.11 | -4.2% | +24.7% | - | |
| Sep 18, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 7,022 | $40.26 | $282,731.70 | -18.3% | +0.1% | - | |
| Sep 18, 2025 | LLY Eli Lilly & Co | Lilly Endowment Inc | - | Sell | 106,626 | $764.65 | $81,531,958.91 | - | +36.6% | - | |
| Sep 18, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $402.29 | $3,218,352.01 | -64.5% | +24.7% | - | |
| Sep 17, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $50.50 | $133,168.50 | -1.6% | -26.8% | - | |
| Sep 17, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 65,110 | $50.57 | $3,292,905.70 | -40.6% | -26.8% | - | |
| Sep 17, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 13,749 | $50.50 | $694,324.50 | -4.4% | -26.8% | - | |
| Sep 17, 2025 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 8,410 | $50.50 | $424,705.00 | -85.6% | -26.8% | - | |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin56 | General Counsel | Sell | 6,267 | $2.80 | $17,572.67 | -1.6% | +36.4% | - | |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | 7,046 | $2.81 | $19,785.17 | -1.5% | +36.4% | - | |
| Sep 17, 2025 | HIMS Hims & Hers Health, Inc. | Carroll Patrick Harrison52 | Chief Medical Officer | Sell | 10,021 | $50.50 | $506,060.50 | -5.6% | -26.8% | - | |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L.63 | President And CEO | Sell | 28,427 | $2.79 | $79,254.48 | -1.8% | +36.4% | - | |
| Sep 16, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 4,000 | $400.27 | $1,601,062.10 | -55.1% | +25.7% | - | |
| Sep 16, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 175,661 | $53.42 | $9,384,625.36 | -10.1% | -28.8% | - | |
| Sep 15, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 16,400 | $36.46 | $597,975.80 | -19.1% | +13.6% | - | |
| Sep 15, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $400.56 | $9,012,624.13 | -21.9% | +24.1% | - | |
| Sep 15, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 4,150 | $56.00 | $232,400.00 | -1.5% | -32.8% | - | |
| Sep 15, 2025 | LQDA Liquidia Corp | Singh Raman | Director | Sell | 45,524 | $25.81 | $1,174,974.44 | -59.3% | +27.7% | - | |
| Sep 15, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 145,000 | $55.35 | $8,026,075.61 | -33.7% | -32.8% | - | |
| Sep 15, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $400.93 | $3,207,435.64 | -52.9% | +24.1% | - | |
| Sep 12, 2025 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 400 | $98.42 | $39,368.00 | -0.5% | -15.9% | - | |
| Sep 12, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | 5,000 | $45.87 | $229,350.00 | -24.4% | +2.3% | - | |
| Sep 12, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 48,600 | $0.25 | $12,150.00 | -1.0% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.